期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
Is"Pangolin(Manis Squama)is not used in medicine"an improvement in the protection of precious and rare species or an improvement in the safety of using medicine?
1
作者 Bao-Tong Li Yi Zhou +1 位作者 Xiao-Juan Su Xiang-Long Meng 《Traditional Medicine Research》 2020年第6期425-427,共3页
Recently,a number of reports about pangolin have become hot news:The Chinese Pharmacopoeia(2020 edition)has not continued to include the drug-using standards for pangolin(Manis Squama),aristolochic(Aristolochia debili... Recently,a number of reports about pangolin have become hot news:The Chinese Pharmacopoeia(2020 edition)has not continued to include the drug-using standards for pangolin(Manis Squama),aristolochic(Aristolochia debilis Sieb.et Zucc),celestial vine(Fibraurea recisa Pierre),and Chinese patent drug Huanglian Yanggan pills(approval number by China State Food and Drug Administration:Z200113194).On June 5,2020,the China Forestry Administration Bureau and the Grassland Bureau co-issued an announcement to upgrade all the species of genus pangolins from the national second level of the protected wildlife to the first level.The new coronavirus(SARS-CoV-2)is also highly similar to the beta coronavirus isolated from pangolin[1]. 展开更多
关键词 APPROVAL continued protected
下载PDF
Mechanism of dihydrotanshinone I in the treatment of helicobacter pylori infection based on network pharmacology and molecular docking technology
2
作者 Yun-Feng Yu Man-Li Zhou +1 位作者 Yi-Pei Wang Ying Zhu 《Medical Data Mining》 2022年第2期28-35,共8页
Objective:Based on the network pharmacology approach and molecular docking technology,the core targets of dihydrotanshinone I(DHT)for the treatment of helicobacter pylori(Hp)infection were searched and the potential m... Objective:Based on the network pharmacology approach and molecular docking technology,the core targets of dihydrotanshinone I(DHT)for the treatment of helicobacter pylori(Hp)infection were searched and the potential mechanisms of drug therapy were explored.Methods:The TCMSPdatabase and Swiss Target Prediction database were employed to identify drug targets.To mine disease targets based on GeneCards,OMIM,DrugBank,DisGeNET,and TTDdatabases.Then the two were intersected to obtain common targets.The proteinproteininteraction(PPI)networkmap of common targets was constructed on the basis of the String network platform and Cytoscape software,and the targets with degree values over 1/2 maximum degree value were selected as core targets.Molecular docking verification of DHTand core targets were performed using AutoDock and PyMOL software.Finally,gene ontology(GO)functional enrichment analysis andKyoto Encyclopediaof Genes and Genomes(KEGG)pathway enrichment analysis of the common targets were carried out using the Metascape database and R-4.0.2-win software.Results:A total of 13 targets of DHTwas extracted for the treatment of Hp,and five core targets,includingSignal transducerand activator of transcription 1(STAT1),Signal transducerand activator of transcription 3(STAT3),Prostaglandin G synthase 2(PTGS2),Signal transducerand activator of transcription 4(STAT4)and Indoleamine 2,3-dioxygenase 1(IDO1),were screened according to their degree values.Molecular docking indicated that DHThad an excellent binding to the core target.29 pathways were yielded by KEGG enrichment analysis,and a total of 48 biological processes,7 cellular components and 13 molecular functions were derived from GO enrichment analysis.Conclusion:DHTmay decrease pro-inflammatory factor expression and immune cell infiltration to treat Hpinfection via the janus kinase(JAK)-signal transducer and activator of transcription(STAT)signaling pathway regulated by STAT1,STAT3,STAT4,etc. 展开更多
关键词 dihydrotanshinone helicobacter pylori mechanism of action network pharmacology molecular docking
下载PDF
Naringin Inhibits Colorectal Carcinogenesis by Inhibiting Viability of Colorectal Cancer Cells
3
作者 ZENG Juan-ni TAN Jin-yu MO Li 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2023年第8期707-713,共7页
Objective To explore the therapeutic effect of naringin on colorectal cancer(CRC)and the related mechanism.Methods Cell counting kit-8(CCK-8)assay and annexin V-FITC/PI assay were used to detect the effect of naringin... Objective To explore the therapeutic effect of naringin on colorectal cancer(CRC)and the related mechanism.Methods Cell counting kit-8(CCK-8)assay and annexin V-FITC/PI assay were used to detect the effect of naringin(50–400µg/mL)on cell proliferation and apoptosis of CRC cells,respectively.The scratch wound assay and transwell migration assay were used to assess the effect of naringin on CRC cell migration.Four-week-old male nude mice were injected with HCT116 cells subcutaneously to establish the tumor xenograft model.Naringin was injected intraperitoneally at 50 mg/(kg·d),with solvent and 5-fluorouracil treatment as control.The width and length of the tumors were measured and recorded every 6 days,and tumor tissues were photographed and weighed on the last day of the 24-d observation period.Immunohistochemical staining for caspase-3,proliferating cell nuclear antigen and TUNEL assay were used to evaluate the effect of naringin on cell proliferation and apoptosis in tumor tissues.The body weight,food and water intake of mice were recorded,and the major organs in different treatment groups were weighed on the last day and stained with hematoxylin and eosin for histological analysis.Meanwhile,the routine blood indicators were recorded.Results CCK-8 and annexin V-FITC/PI results confirmed that naringin(100,200,and 400µg/mL)could inhibit proliferation and promote apoptosis.The scratch wound assay and transwell migration assay results confirmed the inhibitory activity of naringin against CRC cells migration.In vivo results demonstrated the inhibitory effect of naringin on tumor growth with good bio-compatibility.Conclusion Naringin inhibited colorectal carcinogenesis by inhibiting viability of CRC cells. 展开更多
关键词 apoptosis colorectal cancer migration NARINGIN PROLIFERATION tumor
原文传递
Catharmus tinctorius volatile oil promote the migration of mesenchymal stem cells via ROCK2/Myosin light chain signaling 被引量:1
4
作者 LIU Ya-Mei LI Wang-Yang +11 位作者 XU Liang-Liang YU Li-Juan LUO Yi-Wen LI Xi-Can ZHANG Xun-Chao XIONG Yun-Pu CHEN Hong-Tai ZHU Jun-Lang CHEN Chen XIE Yu-Lu CHEN Dong-Feng WANG Bin 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2019年第7期506-516,共11页
MSC transplantation has been explored as a new clinical approach to stem cell-based therapies for bone diseases in regenerative medicine due to their osteogenic capability. However, only a small population of implante... MSC transplantation has been explored as a new clinical approach to stem cell-based therapies for bone diseases in regenerative medicine due to their osteogenic capability. However, only a small population of implanted MSC could successfully reach the injured areas. Therefore, enhancing MSC migration could be a beneficial strategy to improve the therapeutic potential of cell transplantation. Catharmus tinctorius volatile oil(CTVO) was found to facilitate MSC migration. Further exploration of the underlying molecular mechanism participating in the pro-migratory ability may provide a novel strategy to improve MSC transplantation efficacy. This study indicated that CTVO promotes MSC migration through enhancing ROCK2 mRNA and protein expressions. MSC migration induced by CTVO was blunted by ROCK2 inhibitor, which also decreased myosin light chain(MLC) phosphorylation.Meanwhile, the si RNA for ROCK2 inhibited the effect of CTVO on MSC migration ability and attenuated MLC phosphorylation,suggesting that CTVO may promote BMSC migration via the ROCK2/MLC signaling. Taken together, this study indicates that C.tinctorius volatile oil could enhance MSC migration via ROCK2/MLC signaling in vitro. C. tinctorius volatile oil-targeted therapy could be a beneficial strategy to improve the therapeutic potential of cell transplantation for bone diseases in regenerative medicine. 展开更多
关键词 Catharmus tinctorius VOLATILE oil MSC MIGRATION ROCK2/MLC SIGNALING
原文传递
Efficacy and Mechanism of Buxue Yimu Pillson Gynecological Anemia:A Combination of Clinical and Network Pharmacology Study
5
作者 WANG Yan-fang DENG Yan +6 位作者 ZHANG Su-ying LIU Dong LUO Bin WANG Xue DENG Miao MA Rui-lin SUN Ai-jun 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2022年第12期1072-1080,共9页
Objective:Tocompare the clinical efficacyand safety of oral administration of BuxueYimuPills(BYP),ferrous sulfate(FS),and the combination of BYP and FS on gynecological anemia,and investigate the mechanisms using netw... Objective:Tocompare the clinical efficacyand safety of oral administration of BuxueYimuPills(BYP),ferrous sulfate(FS),and the combination of BYP and FS on gynecological anemia,and investigate the mechanisms using network pharmacology.Methods:A randomized,controlled,multi-center clinical trial was conducted.Totally 150 patients with hemoglobin of 70-110 g/L due to gynecological conditions were recruited and randomized(using the block randomization method)into Buxue Yimu Pills group(24 g/d),oral iron group(FS Tablets,0.9 g/d),and combined treatment group(BYP,24g/d plus FS Tablets,0.9 g/d),50 patients in each group.At the enrollment and 4-week treatment,complete blood count,serum iron indexes were evaluated.Adverse events,liver and renal functions,as well as blood coagulation were observed.Network pharmacology was conducted to identify the active ingredients and explore the potential mechanisms of BYP.Results:Ten(20%)and 7(14%)participants discontinued the therapy due to gastrointestinal symptoms in oral iron and combination treatment groups.All 3 groups showed elevated hemoglobin.The patients in the iron group exhibited typically elevated in serum iron and ferritin and decreased in total iron-binding capacity.No change in iron indexes was observed in BYP group.The patients in the combination treatment group neither showed significant changes in serum ferritin nortotal iron-binding capacity.No significant adverse reactions were observed in the BYP group.The network pharmacology identified 27 bioactive compounds and 145 targets of BYP on gynecological anemia.Biological processes and pathways including regulation of inflammation,hormone,angiogenesis and hemostasis,responsetodecreased oxygen levels,effects on myeloma cell,and responseto metal ions were identified.Conclusion:BYP contributes to the practical improvement on gynecological anemia potentially through multi-target mechanisms and optimized iron re-distribution. 展开更多
关键词 Chinese medicine Buxue Yimu Pills gynecological anemia network pharmacology multi-target mechanism
原文传递
内关、公孙对功能性消化不良大鼠下丘脑-垂体-肾上腺轴的调节作用
6
作者 邢博文 覃思敏 +6 位作者 展立芬 谢云方 伍萍香 江钰 石海斌 何可 刘未艾 《Journal of Acupuncture and Tuina Science》 CAS CSCD 2023年第4期247-253,共7页
目的:探讨内关、公孙对功能性消化不良(FD)模型大鼠下丘脑-垂体-肾上腺(HPA)轴的作用及可能机制,为八脉交会穴的临床应用提供理论依据.方法:将40只无特定病原体级Sprague-Dawley大鼠采用随机数字表法分为空白组、模型组、电针组和西药组... 目的:探讨内关、公孙对功能性消化不良(FD)模型大鼠下丘脑-垂体-肾上腺(HPA)轴的作用及可能机制,为八脉交会穴的临床应用提供理论依据.方法:将40只无特定病原体级Sprague-Dawley大鼠采用随机数字表法分为空白组、模型组、电针组和西药组,每组10只.空白组不造模,不干预.其他三组采用复合病因造模法制作FD伴情绪障碍模型.模型成功后,模型组不干预;西药组灌服黛力新合莫沙必利;电针组行电针干预,穴取同侧内关、公孙.治疗21 d.分别于实验前及治疗前后检测糖水消耗率以评定情绪状态;治疗后检测胃排空率评定胃肠动力;应用酶联免疫吸附法检测下丘脑促肾上腺皮质激素释放激素(CRH)、垂体促肾上腺皮质激素(ACTH)及肾上腺皮质酮(CORT)的表达水平.结果:与空白组相比较,模型组大鼠糖水消耗率及胃排空率均下降(P<0.01);下丘脑CRH、垂体ACTH及肾上腺CORT表达水平均上升(P<0.01).与模型组相比较,电针组和西药组大鼠糖水消耗率及胃排空率均明显提升(P<0.01);下丘脑CRH、垂体ACTH及肾上腺CORT表达水平明显下降(P<0.01).电针组与西药组各项差异均无统计学意义(P>0.05).结论:八脉交会穴之内关、公孙能改善FD大鼠的情绪及胃肠动力;其作用机制可能与降低下丘脑CRH、垂体ACTH和肾上腺CORT表达水平,纠正HPA轴功能亢进有关. 展开更多
关键词 针刺疗法 电针 消化不良 八脉交会穴 内关 公孙 下丘脑-垂体-肾上腺轴
原文传递
针刺加耳穴贴压对脑卒中后抑郁患者心率变异性的影响(英文) 被引量:13
7
作者 张林 钟艳 +4 位作者 全淑林 石学慧 李振光 王净净 吴江昀(译) 《Journal of Acupuncture and Tuina Science》 CSCD 2017年第6期392-397,共6页
目的:观察针刺加耳穴贴压治疗对脑卒中后抑郁患者心率变异性(HRV)的影响。方法:将80名脑卒中后抑郁患者随机分为治疗组和对照组,每组40例。对照组口服盐酸帕罗西汀片,治疗组在口服相同药物基础上加用针刺和耳穴贴压治疗。比较治疗前后... 目的:观察针刺加耳穴贴压治疗对脑卒中后抑郁患者心率变异性(HRV)的影响。方法:将80名脑卒中后抑郁患者随机分为治疗组和对照组,每组40例。对照组口服盐酸帕罗西汀片,治疗组在口服相同药物基础上加用针刺和耳穴贴压治疗。比较治疗前后两组患者汉密尔顿抑郁量表(HAMD)评分及HRV变化。结果:治疗8星期后,两组HAMD各因子评分及总分均较本组治疗前下降(均P<0.05);治疗组焦虑/躯体化因子、睡眠障碍因子、绝望感因子、认知因子及总分分值均低于对照组(均P<0.05)。治疗8星期后,两组24 h内窦性心律R-R间期标准差(SDNN)、每5 min窦性心率的R-R间期平均值标准差(SDANN)、24 h内窦性心律相邻R-R间期差值的均方根(RMSSD)、24 h内相邻窦性心率R-R间期差大于50 ms的个数占百分比(PNN50)及高频成分(HF)均较治疗前增加,低频成分(LF)及低频高频比(LF/HF)均较治疗前降低,组内差异均有统计学意义(均P<0.05);治疗组各项指标与对照组均有统计学差异(均P<0.05)。结论:在常规药物治疗基础上加用针刺和耳穴贴压可增强常规药物治疗对脑卒中后抑郁患者HRV的改善作用。 展开更多
关键词 针刺疗法 耳穴贴压 中风 并发症 心率 抑郁
原文传递
隔药饼灸对高脂血症兔调脂通路Leptin/JAK2/STAT3的影响 被引量:3
8
作者 廖宗力 谭静 +4 位作者 朱重政 孙璐 黄文韬 阳仁达 常小荣 《Journal of Acupuncture and Tuina Science》 CSCD 2019年第6期371-382,共12页
目的:观察不同促透剂运用于隔药饼灸对高脂模型兔降脂效果的影响,探讨其可能机制。方法:将40只新西兰兔按随机数字表法随机分成5组,每组8只。空白组正常喂养普通饲料;其余组高脂饲料喂养12周,复制高脂模型。空白组和模型组不治疗。无促... 目的:观察不同促透剂运用于隔药饼灸对高脂模型兔降脂效果的影响,探讨其可能机制。方法:将40只新西兰兔按随机数字表法随机分成5组,每组8只。空白组正常喂养普通饲料;其余组高脂饲料喂养12周,复制高脂模型。空白组和模型组不治疗。无促透剂组成模后采用不加促透剂药饼施灸;氮酮组和冰片组分别将氮酮和冰片用于药饼中,进行隔药饼灸。治疗4周后,分离血清进行酶联免疫吸附测定(ELISA),分离肝脏组织进行免疫组化、定量聚合酶链式反应(qPCR)和蛋白免疫印迹(WB)检测。结果:血清ELISA检测结果显示,与空白组比较,模型组Leptin显著下降(PV0.05);与模型组比较,无促透剂组、氮酮组和冰片组Leptin显著升高(均PV0.05);与无促透剂组比较,氮酮组和冰片组Leptin均显著升高(均PV0.05);氮酮组和冰片组Leptin差异无统计学意义(P>0.05)。兔肝脏组织qPCR结果显示,与空白组比较,模型组Leptin JAK2和STAT3 mRNA表达显著降低(均PV0.05);与模型组比较,无促透剂组、氮酮组和冰片组Leptin、Leptin受体、JAK2和STAT3 mRNA表达显著升高(均PV0.05);与无促透剂组相比,氮酮组和冰片组的Leptin.Leptin受体、JAK2和STAT3 mRNA表达显著升高(均PV0.05);与氮酮组比较,冰片组的Leptin、Leptin受体、JAK2和STAT3 mRNA表达显著升高(均PV0.05)。免疫组化和WB检测趋势与qPCR结果基本一致。磷酸化JAK2(Phospho-JAK2)和磷酸化STAT3(phospho-STAT3)免疫组化和WB检测趋势与JAK2和STAT3基本一致。结论:高脂模型兔的Leptin/JAK"STAT3通路分子表达下降,隔药饼灸后Leptin/JAK?/STAT3通路因子表达显著上升,氮酮和冰片作为促透剂运用于隔药饼灸比单纯隔药饼灸对Leptin/JAK刀STAT3调脂通路相关因子的上调作用更明显。 展开更多
关键词 灸法 间接灸 药饼灸疗法 高脂血症 月桂氮酮 Janus激酶2/STAT3通路 瘦素
原文传递
不同促透剂用于隔药饼灸对高脂血症兔肝脏脂质及HSL和HMG-CoA还原酶的影响 被引量:3
9
作者 廖宗力 朱重政 +6 位作者 谭静 罗凤姣 孙璐 黄文韬 陈艳萍 阳仁达 常小荣 《Journal of Acupuncture and Tuina Science》 CSCD 2020年第3期157-164,共8页
目的:探讨冰片和氮酮作为促透剂用于隔药饼灸对高脂血症兔肝脏脂质及激素敏感脂肪酶(HSL)和羟甲基戊二酰辅酶A(HMG-CoA)还原酶的影响.方法:将40只新西兰兔按随机数字表法随机分成5组,每组8只.空白组正常喂养普通饲料;其余组高脂饲料喂... 目的:探讨冰片和氮酮作为促透剂用于隔药饼灸对高脂血症兔肝脏脂质及激素敏感脂肪酶(HSL)和羟甲基戊二酰辅酶A(HMG-CoA)还原酶的影响.方法:将40只新西兰兔按随机数字表法随机分成5组,每组8只.空白组正常喂养普通饲料;其余组高脂饲料喂养12周,复制高脂模型.空白组和模型组不治疗.无促透剂组成模后采用不加促透剂的药饼施灸;氮酮组和冰片组分别将氮酮和冰片加于药饼中,进行隔药饼灸.治疗4周后,分离血清,酶联免疫吸附法(ELISA)检测HSL和HMG-CoA还原酶.取肝组织采用酶法测定总胆固醇(TC)和甘油三酯(TG),直接一步法测定高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C),透射比浊法测定载脂蛋白A1(Apo-A1)及载脂蛋白B(Apo-B).结果:氮酮组和冰片组血清药物浓度显著高于无促透剂组(均P<0.05);除丹参酮ⅡA外,冰片组其他药物渗透量均显著高于氮酮组(均P<0.05).氮酮组和冰片组HSL显著高于无促透剂组,HMG-CoA还原酶显著低于无促透剂组(均P<0.05);冰片组HSL显著高于氮酮组(P<0.05).模型组兔肝脏LDL-C、TG、TC和Apo-B含量显著高于空白组(P<0.05);无促透剂组、氮酮组和冰片组LDL-C、TG、TC及Apo-B含量显著低于模型组(均P<0.05),氮酮组TG和TC显著低于无促透剂组(均P<0.05),冰片组LDL-C、TG、TC和Apo-B显著低于无促透剂组(均P<0.05);冰片组TG、LDL-C和Apo-B显著低于氮酮组(均P<0.05);模型组HDL-C和Apo-A1显著低于空白组(均P<0.05),无促透剂组、氮酮组和冰片组HDL-C及Apo-A1显著高于模型组(均P<0.05),氮酮组Apo-A1、冰片组HDL-C及Apo-A1均显著高于无促透剂组(均P<0.05).结论:氮酮和冰片作为促透剂用于隔药饼灸,能促进药饼中药物吸收,降低肝脏TC、TG、LDL-C和Apo-B含量,提高HDL-C和Apo-A1含量,改善HSL和HMG-CoA还原酶的代谢;冰片效果略优于或相当于氮酮. 展开更多
关键词 灸法 药饼灸疗法 高脂血症 月桂氮酮 冰片 甾醇酯酶 HMG-COA还原酶
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部